Medical Abortion for Emergency Contraception Failure

Status Completed

Clinical Trial Summary

The purpose of this study is to compare the efficacy, safety and acceptability of pre-treatment with mifepristone and misoprostol compared to misoprostol alone in the medical termination of pregnancy by mifepristone EC failure.

Clinical Trial Description

Women usually request an abortion when they have experienced an emergency contraception (EC) failure; this population represents 13% of all early pregnancy terminations in China. Many women would prefer to choose a medical abortion in order to avoid anesthesia, over a surgical operation. However, medical termination of a pregnancy after mifepristone EC failure has not been studied although it has already been extensively practiced by empirical means in China. There is no clarification in literature as to whether mifepristone is still effective in medical abortion with its previous failure experience in EC. This randomized study was aimed to compare the efficacy, safety and acceptability of pre-treatment with mifepristone and misoprostol compared to misoprostol alone in the medical termination of pregnancy by mifepristone EC failure. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00677755
Study type	Interventional
Source	Taizhou Hospital
Contact
Status	Completed
Phase	N/A
Start date	October 2004
Completion date	November 2007

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01541293` - Intrauterine Lidocaine for Laminaria	Phase 1
Completed	`NCT00177333` - Serum Levels of Doxycycline at the Time of Abortion With Two Dosing Regimens	Phase 4
Completed	`NCT00370487` - Comparison of the Safety of First Trimester Abortions Performed by Physicians and Non-Physicians in South Africa and Viet Nam.	N/A
Completed	`NCT00188071` - Postoperative Pain After Medical Abortion Under Local Anesthesia : Comparison of Several Analgesic Regimen	N/A
Completed	`NCT02277249` - Transvaginal Versus Transabdominal Digoxin Prior to Second-trimester Abortion	N/A
Completed	`NCT00386867` - A Randomized Trial of Buccal Compared to Oral Misoprostol Following Mifepristone for Medical Abortion up to 63 Days LMP	N/A
Completed	`NCT02279914` - Misoprostol Dose and Timing Before Surgical Abortion at 13 to 16 Weeks' Gestation: a Randomized Trial	N/A
Completed	`NCT01597726` - Cervical Priming Before Dilation & Evacuation	N/A
Completed	`NCT01615731` - Value of Mifepristone in Cervical Preparation Prior to Dilation and Evacuation 19-24 Weeks	N/A
Completed	`NCT02318212` - Dilapan-S / Dilasoft E-Registry in Induced Abortion	N/A
Terminated	`NCT00855842` - Pilot Study of the Addition of Osmotic Dilators to Preparation Prior to Labor Induction Abortion	N/A
Completed	`NCT00330993` - Oral Mifepristone and Buccal Misoprostol Administered Simultaneously for Abortion Through 63 Days Gestation	Phase 2
Completed	`NCT00382538` - Mifepristone and Mid-Trimester Termination of Pregnancy	N/A
Completed	`NCT03080493` - Gabapentin for Pain Control After Osmotic Dilator Insertion and Prior to D&E Procedure: a Randomized Controlled Trial	Phase 4
Completed	`NCT02485444` - Oxytocin Infusion vs. Spontaneous Follow-up for Third-stage of Labor After Second-trimester Abortion	Phase 4
Completed	`NCT00969982` - Mifepristone Plus Misoprostol Versus Misoprostol Alone for 2nd Trimester Abortion (14 - 21 Weeks Last Menstrual Period (LMP))	N/A
Recruiting	`NCT02480543` - Different Routes of Misoprostol Prior to First Trimester Surgical Abortion	Phase 4
Completed	`NCT00870272` - Study of 400mcg Sublingual Versus 400mcg Buccal Misoprostol Following 200mg Mifepristone for Medical Abortion up to 63 Days Last Menstrual Period (LMP)	N/A
Completed	`NCT02048098` - Misoprostol for Second Trimester Termination of Pregnancy	Phase 3
Completed	`NCT01751087` - Cervical Preparation Before Dilation and Evacuation	N/A